Cargando…
Effects of interleukin-2 and interferon-alpha A/D treatment on lymphocytes from tumour-bearing mice.
The in vivo antitumour activities of recombinant human interleukin-2 (rHIL-2) and recombinant human hybrid interferon alpha A/D (rIFN-alpha A/D) were tested in relation to adenocarcinoma 755. The tumour growth, following s.c. inoculation of tumour cells, was inhibited to a greater extent in mice tre...
Autores principales: | Ligo, M., Nakajima, Y., Nishikata, K., Hoshi, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246732/ https://www.ncbi.nlm.nih.gov/pubmed/2786729 |
Ejemplares similares
-
Changes in Lymphocyte Subsets Following Multiple Administration of Recombinant Interleukin‐2 plus Recombinant Interferon‐beta or ‐gamma in Tumor‐bearing Mice
por: Iigo, Masaaki, et al.
Publicado: (1989) -
Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.
por: Håkansson, A., et al.
Publicado: (1996) -
Interleukin-1 production by immunologically hyporeactive tumour-bearing mice.
por: Holán, V., et al.
Publicado: (1990) -
Effects of anthracycline derivatives on hepatic neoplastic nodules of Lewis lung carcinoma and colon adenocarcinoma 26.
por: Iigo, M., et al.
Publicado: (1991) -
Thyroiditis after treatment with interleukin-2 and interferon alpha-2a.
por: Pichert, G., et al.
Publicado: (1990)